HOT NEWS
Boehringer Ingelheim launches 'Lean-to-Clinic' program for fast drug product sup... » Boehringer Ingelheim has expanded its biopharmaceutical cell line development services and provides ...
43 research talents awarded scholarships to help secure Denmark's future » 43 of Denmark's most talented students in the biotechnological and pharmaceutical sciences will toda...
Novartis drug Signifor® recommended by CHMP for EU approval » The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) ado...
Genzyme Announces European Approval of Framingham Manufacturing Plant » Sanofi (EURONEXT: SAN and NYSE: SNY) and its subsidiary Genzyme announced today that the European Me...
AstraZeneca and IMS Health announce real-world evidence collaboration in Europe » AstraZeneca has entered into a three-year collaboration agreement with IMS Health, the leading provi...
MyAsthma App - a New Dimension in Asthma Control » GlaxoSmithKline (GSK) has announced the launch of MyAsthma, the UK's first, free personalised health...
Shire's Venvanse® (lisdexamfetamine dimesylate) Marketing Application accepted ... » Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced...
Bayer's Xarelto® (Rivaroxaban) Submitted for EU Marketing Authorisation for Sec... » Bayer HealthCare has submitted an application for marketing authorization to the European Medicines ...
Avastin receives EU approval for the treatment of women with newly diagnosed, ad... » Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that the European Commission has approved Avastin (beva...
First-of-its-Kind Endovascular Trial of the Investigational Esprit(TM) Therapy » Abbott (NYSE: ABT) today announced the initiation of ESPRIT I, a first-of-its-kind clinical trial in...
GlaxoSmithKline
GlaxoSmithKline (GSK)GlaxoSmithKline - one of the world's leading research-based pharmaceutical and healthcare companies - is committed to improving the quality of human life by enabling people to do more, feel better and live longer. For more information, visit www.gsk.com.

GlaxoSmithKline RSS Channel
Title Filter     Display # 
# Article Title Hits
1 MyAsthma App - a New Dimension in Asthma Control 1623
2 GlaxoSmithKline welcomes innovative knowledge-sharing collaboration 2451
3 Data published in The Lancet Oncology support high efficacy previously demonstrated by Cervarix® 2424
4 GSK delivers strong Q3 performance with underlying sales growth 2691
5 GlaxoSmithKline (GSK) and McLaren Group announce innovative strategic partnership 4141
6 GSK and Enigma Diagnostics announce collaboration 4281
7 GlaxoSmithKline European regulatory update on Pandemrix™ 4640
8 GlaxoSmithKline and Human Genome Sciences receive European authorisation for Benlysta® 4455
9 GlaxoSmithKline and Human Genome Sciences receive positive opinion in Europe from the CHMP for Benlysta® (belimumab) 5415
10 Pharmaceutical industry and university create Manchester Collaborative Centre for Inflammation Research 5288
11 Unique Research Alliance Expands Collaboration Opportunities 5696
12 GSK statement on Avodart™ (dutasteride) for prostate cancer risk reduction 5685
13 GSK outlines new plan to drive recruitment and attract graduate talent in the UK 5636
14 GSK's full year trading update 5761
15 GSK and Valeant receive positive opinion for Trobalt (retigabine) 5777
16 GSK responds to 60 Minutes | Related Video 5067
17 GSK to strengthen Nutritional Healthcare business with acquisition of Maxinutrition 4450
18 GlaxoSmithKline and JSC Binnopharm enter vaccine production alliance in Russia 5017
19 GSK, Fondazione Telethon and Fondazione San Raffaele to collaborate on gene therapy 5111
20 GlaxoSmithKline receives EU approval for a new therapeutic indication for Arixtra® 4557
 
  • «
  •  Start 
  •  Prev 
  •  1 
  •  2 
  •  3 
  •  Next 
  •  End 
  • »
Page 1 of 3
Bookmark and Share